This webinar provides a high-level overview of the new In-vitro Diagnostics EU Regulation (IVDR) that came into effect as of May 26th, 2022, and the implications for institutions offering laboratory-developed tests (LDTs).
In this session, we will focus on the impact for your laboratory, and provide some practical guidance to help with a smooth transition to digital pathology. From pragmatic considerations, when selecting a scanner, to workflow implications, this webinar aims to arm you with the information needed to identify the right solution.
Associate Director of Pathology Informatics, Johns Hopkins Medicine
In recent years, digital pathology has gone from an intriguing idea to an integral part of how academic and commercial labs operate. Join Leica Biosystems and Procia Digital Pathology as they discuss why institutions are going digital today and how they...
Pathologist – Seattle Cancer Care Alliance, Assistant Professor – University of Washington, Dept. of Pathology
In this session, we will briefly review the basics of molecular biology, examine critical factors which affect the quality of nucleic acids in the tissues and cells which are submitted for downstream molecular diagnostics, and briefly introduce some...
Möchten Sie, dass wir Ihren Text veröffentlichen?
Wir sind stets auf der Suche nach weiteren interessanten Autoren, die wir hier vorstellen möchten. Reichen Sie Ihren Beitrag ein und wir melden uns bei Ihnen!